Creyon: Creyon Bio Announces David Fajgenbaum as Company Advisor and Board Observer
SAN DIEGO, RESEARCH TRIANGLE PARK, NC - May 17, 2022 - Creyon Bio, Inc. ("Creyon Bio"), a drug development company engineering RNA-based medicines and their components (oligonu...
Read full article »
Creyon is a California-based preclinical stage company that researches and commercializes oligonucleotide medicines for the treatment of respiratory diseases.
Read more